The study introduced the AVaTAR procedure for congenital heart defects, showing that it creates a functional semilunar valve reconstruction that can adapt to a child's growth while maintaining proper function.
We found very promising results in our in vivo test in porcine model, with the neo-valves showing no significant stenosis or regurgitation.
Our neo-valves have unique features that allow for accommodation to growth in pediatric patients. Mid-term follow-up shows promising results and encourages us to keep moving forward.